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thors called for a more selective use of TME. The authors argue 
that oncologic outcome is not compromised with this approach 
based on similar cancer-specific survival patterns between TME 
and PME in this study. This conclusion was confirmed by meta-
analysis. Mirnezami et al. [6] examined the long-term oncological 
impact of anastomotic leakage after rectal cancer surgery using 
meta-analysis methods. They found that anastomotic leakage     
has a negative impact on local recurrence after the rectal cancer 
surgery. A significant association between anastomotic leakage 
and reduced long-term cancer specific survival was also noted. 
Junginger and Hermanek [7] reviewed the literature concerning 
oncologic outcomes after the rectal surgery. The authors recom-
mended PME, if the rectal cancer is located 12 to 16 cm from anal 
verge. 
Oncologic outcomes after the rectal cancer surgery can be di-
vided into the long-term survival and the local recurrence rate. 
Regarding rectal cancer, local recurrence rate is especially impor-
tant compared to colon cancer. TSME itself and its quality is one 
of the most important factors to predict the local recurrence and 
even the long-term survival after rectal cancer surgery. Survival     
is mainly determined by the occurrence of distant metastasis, but 
TME seems to improve survival in patients without systemic dis-
ease. Therefore, the effort to improve the quality of TME is so cru-
cial to improve oncologic outcomes after rectal cancer surgery. 
Preoperative concurrent chemoradiotherapy is another important 
factor to reduce the local failure. Pathologic results, such as distal 
margin, circumferential radial margin, T and N stage, lymphatic 
and vascular invasion, neural invasion, are also important factors 
to influence the oncologic results after TSME.
In conclusion, surgeon is one of the most important factors to 
predicting oncologic outcomes after TME. Individual surgeon 
should make an effort to improve surgical skill and pathologist 
can help him with the specimen audit. Nationwide audit program 
is needed to improve the oncologic results after TME in rectal can-
cer in South Korea. The other important factor is the preoperative 
radiotherapy. Preoperative radiotherapy with high quality TME 
can almost abolish the possibility of local recurrence. 
Total mesorectal excision (TME) was proposed by Heald et al. [1] 
more than 20 years ago and it is defined as the complete excision 
of the visceral mesorectal tissue to the level of the levators. The lo-
cal    recurrence rate after rectal cancer surgery has decreased dra-
matically to below 10% thanks to this TME technique. Currently 
TME is the gold standard for treatment of rectal cancer. However, 
if   the tumor is located in upper rectum, partial mesorectal exci-
sion (PME) down to 5 cm below tumor can be performed. In 
1998, Lopez-Kostner et al. [2] from Cleveland clinic insisted that 
TME is not necessary in case of the upper rectal cancer. And in 
the same year, Zaheer et al. [3] from Mayo clinic stated that ap-
propriate “tumor-specific” mesorectal excision during anterior re-
section when tumor is high in the rectum is likewise consistent 
with a low rate of local recurrence and good long-term survival. 
The term tumor-specific mesorectal excision (TSME) was noted 
first in this article. In the Europe, Maurer et al. [4] from Germany 
concluded that the rectal cancers of upper third are appropriately 
treated by PME to 5 cm below the tumor. TSME is defined as the 
precise perpendicular and circumferential excision of the meso-
rectum to the level of an appropriate distal resection margin by 
American Society of Colon and Rectal Surgeons. 
Law and Chu et al. [5] from Queen Mary’s Hospital in Hong 
Kong compared the patients with TME for mid and lower rectal 
cancer and PME for upper rectal cancer, where the rectum was 
transected 4 to 5 cm below the tumor. Due to longer operative 
times, higher anastomotic leak rates, a more technically demand-
ing surgery and a higher incidence of stoma formation, the au-
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